KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) Return on Equity (2018 - 2025)

Historic Return on Equity for Bionano Genomics (BNGO) over the last 8 years, with Q3 2025 value amounting to 0.81%.

  • Bionano Genomics' Return on Equity rose 12900.0% to 0.81% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.81%, marking a year-over-year increase of 12900.0%. This contributed to the annual value of 1.7% for FY2024, which is 3600.0% down from last year.
  • Per Bionano Genomics' latest filing, its Return on Equity stood at 0.81% for Q3 2025, which was up 12900.0% from 1.59% recorded in Q2 2025.
  • Bionano Genomics' Return on Equity's 5-year high stood at 0.14% during Q2 2021, with a 5-year trough of 2.66% in Q4 2024.
  • Its 5-year average for Return on Equity is 1.12%, with a median of 0.66% in 2023.
  • Over the last 5 years, Bionano Genomics' Return on Equity had its largest YoY gain of 403500bps in 2021, and its largest YoY loss of -1085800bps in 2021.
  • Over the past 5 years, Bionano Genomics' Return on Equity (Quarter) stood at 0.21% in 2021, then tumbled by -134bps to 0.5% in 2022, then plummeted by -333bps to 2.16% in 2023, then fell by -23bps to 2.66% in 2024, then surged by 70bps to 0.81% in 2025.
  • Its Return on Equity stands at 0.81% for Q3 2025, versus 1.59% for Q2 2025 and 2.0% for Q1 2025.